Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Latest press releases
- Oncologic Drugs Advisory Committee to review Zejula overall survival data from the NOVA phase III trial in recurrent ovarian cancer
- GSK and Spero Therapeutics announce exclusive licence agreement for tebipenem HBr, a late-stage antibiotic that may treat complicated urinary tract infections
- GSK announces update on US FDA regulatory review of daprodustat in anaemia of chronic kidney disease
- US FDA accepts new drug application for GSK’s momelotinib for the treatment of myelofibrosis
Follow @GSKUS on Twitter
-
Today, October 5th, is #WorldMeningitisDay2022. GSK stands with our partners in helping to #DefeatMeningitis, raise awareness and prioritize addressing #meningitis on a global scale.
-
Did you know that bacterial meningitis and neonatal sepsis together are bigger killers than malaria, measles and tetanus combined? 👀#DefeatMeningitiss#WorldMeningitisDay202226
-
During her 10 years at GSK, our colleague Jennifer Gould has used creativity, collaboration and AI to innovate the way we work. Congrats for being recognized as a #PharmaVoice100 Disrupter 👏 Learn what inspires Jennifer here:gsk.to/3LZdpVSMl
-
Proud to share recognition from the Hispanic Association on Corporate Responsibility, @HACRORG, during #HispanicHeritageMonth. This award reflects our year-round commitment to #DEI for our people, our patients and our communities. #HACRSYM22
